Monthly archive | PharmaTutor

28 September 2016

Career for Research Scientist II - Stability Coordinator in Albany Molecular Research Inc.

For more than 20 years, as Albany Molecular Research Inc. (AMRI), we have provided fully integrated drug discovery, development and manufacturing services – all while adapting to the rapidly changing needs of our customers within the pharmaceutical, biotechnology and related industries.
With locations in the United States, Europe and Asia, AMRI SMARTSOURCING™ offers you a versatile and strategic way of partnering with us that is designed to deliver reduced risk, greater flexibility and a better return on investment. AMRI has successfully partnered R&D programs and is actively seeking to out-license its remaining programs for further development.

Post:Reserch Scientist II - Stability Coordinator - 1000444

28 September 2016

5th Indo- African international Conference in Shri Vishnu College of Pharmacy

Padmabhushan Dr B.V. Raju Foundation’s Shri Vishnu College of Pharmacy in association with Association of Pharmacy Professionals conducted 5th Indo-African international Conference on “Recent Trends and Future Development in Pharmaceutical Sector” on 1st September 2016.

Read more about U.S. FDA grant Orphan Drug Designation to Soricimed’s SOR-C13

Soricimed Biopharma Inc. announce that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to peptide SOR-C13 for the treatment of pancreatic cancer. This follows the same designation for ovarian cancer.

Read more about Amgen present Top-Line Results From Phase 3 KYPROLIS® CLARION Study

Amgen announced top-line results of the Phase 3 CLARION trial, which evaluated an investigational regimen of KYPROLIS® (carfilzomib), melphalan and prednisone (KMP) versus Velcade® (bortezomib), melphalan and prednisone (VMP) for 54 weeks in patients with newly diagnosed multiple myeloma who were ineligible for hematopoietic stem-cell transplant. The trial did not meet the primary endpoint of superiority in progression-free survival (PFS) (median PFS 22.3 months for KMP versus 22.1 months for VMP, HR = 0.91, 95 percent CI, 0.75 - 1.10). While the data for overall survival, a secondary endpoint, are not yet mature, the observed hazard ratio (KMP versus VMP) was 1.21 (95 percent CI, 0.90 - 1.64). Neither result was statistically significant.

Read more about Amgen And UCB declare U.S. FDA Accept BLA Application For Romosozumab

Amgen and UCB announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Biologics License Application (BLA) for romosozumab, an investigational monoclonal antibody for the treatment of osteoporosis in postmenopausal women at increased risk of fracture.

27 September 2016

Career for Pharmacist in Office of the Medical Supe rintendent | Govt. Jobs

Applications are invited from the eligible candidates for filling up various posts of Group ‘C, Group ‘B’ (NonGazetted) on Direct recruitment/Deputation basis in VMMC & Safdarjang Hospital, New Delhi. Details of posts including number of vacancies, pay band and grade pay, category, age, requisite qualification, experience are a s under

Post : Pharmacist

27 September 2016

Recruitment of Sr.Operation Specialist in Quintiles | walk in

It is a Fortune 500 company and the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 32,000 employees conducting business in approximately 100 countries

Post: Sr.Operation Specialist

27 September 2016

Walk in interview for junior research fellow at IICB - 40 posts

The Institute was established in 1935 as the first non official centre in India for biomedical research and was included within the aegis of CSIR in 1956. IICB today is engaged in research on diseases of national importance and biological problems of global interest, employing sophisticated state-of-the-art technology in keeping with the rapid and unprecedented momentum that life science research has gained globally over the last 50 years.

Post : junior research fellow - 40 posts

27 September 2016

Research Opportunities for exceptionally talented and strongly motivated students at TIFR

The Tata Institute of Fundamental Research was conceived and founded by the distinguished Indian Scientist Dr. Homi Bhabha in June 1945 with the active support of the Sir Dorabji Tata Trust and the Government of Bombay Presidency. In 1962, the Institute shifted to its present picturesque campus at Colaba on the shores of the Arabian Sea.
At TIFR, research is carried out in frontline areas of all the fundamental sciences: Biology, Chemistry, Computer Science, Mathematics and Physics, as well as in the field of Science Education. TIFR Scientists are world leaders in several fields and their published contributions to scientific knowledge are internationally recognised. Over the years, the Institute has developed many new areas of research as well as training programmes.

27 September 2016

Career as Clinical Trial Assistant in Icon Clinical Research

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies
ICON enjoys a strong reputation for quality and is focused on staff development. We make it our mission to attract the most diverse and creative minds into the business and we continually strive to provide opportunities for our people to excel, grow and build a great career. We understand that our greatest asset is the skills and talents of our people and they are truly what set us apart.

Post: Clinical Trial Assistant

Search

September 2016

Career for Research Scientist II - Stability Coordinator in Albany Molecular Research Inc.

RECOMMENDED POSTS

Subscribe with us

Jobs by Category